AU2005215805B2 - Batteries and methods of manufacture and use - Google Patents
Batteries and methods of manufacture and use Download PDFInfo
- Publication number
- AU2005215805B2 AU2005215805B2 AU2005215805A AU2005215805A AU2005215805B2 AU 2005215805 B2 AU2005215805 B2 AU 2005215805B2 AU 2005215805 A AU2005215805 A AU 2005215805A AU 2005215805 A AU2005215805 A AU 2005215805A AU 2005215805 B2 AU2005215805 B2 AU 2005215805B2
- Authority
- AU
- Australia
- Prior art keywords
- reservoirs
- reservoir
- substrate
- silver
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title description 58
- 238000004519 manufacturing process Methods 0.000 title description 13
- 239000000463 material Substances 0.000 claims description 267
- 239000000758 substrate Substances 0.000 claims description 208
- 229910052709 silver Inorganic materials 0.000 claims description 97
- 239000004332 silver Substances 0.000 claims description 97
- 230000004913 activation Effects 0.000 claims description 53
- 239000010410 layer Substances 0.000 claims description 39
- 239000007800 oxidant agent Substances 0.000 claims description 32
- 239000003638 chemical reducing agent Substances 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 30
- 239000012530 fluid Substances 0.000 claims description 27
- 239000011230 binding agent Substances 0.000 claims description 26
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 22
- 229910052725 zinc Inorganic materials 0.000 claims description 22
- 239000011701 zinc Substances 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 13
- 230000035515 penetration Effects 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- 239000012790 adhesive layer Substances 0.000 claims description 5
- 230000015556 catabolic process Effects 0.000 claims description 4
- 238000006731 degradation reaction Methods 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 3
- 239000008151 electrolyte solution Substances 0.000 claims 4
- 230000000593 degrading effect Effects 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 description 178
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 85
- 239000004020 conductor Substances 0.000 description 53
- 208000027418 Wounds and injury Diseases 0.000 description 36
- 206010052428 Wound Diseases 0.000 description 34
- 229910052802 copper Inorganic materials 0.000 description 34
- 239000010949 copper Substances 0.000 description 34
- -1 poly(c-caprolactone) Polymers 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 32
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 32
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 27
- 210000001508 eye Anatomy 0.000 description 26
- 230000006870 function Effects 0.000 description 22
- 230000001413 cellular effect Effects 0.000 description 20
- 230000001225 therapeutic effect Effects 0.000 description 20
- 230000035876 healing Effects 0.000 description 19
- 238000006479 redox reaction Methods 0.000 description 19
- 229910021607 Silver chloride Inorganic materials 0.000 description 18
- 238000004891 communication Methods 0.000 description 18
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 16
- 229910021612 Silver iodide Inorganic materials 0.000 description 16
- 229940096017 silver fluoride Drugs 0.000 description 16
- 229940045105 silver iodide Drugs 0.000 description 16
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 16
- 229910001923 silver oxide Inorganic materials 0.000 description 16
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 15
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 14
- 239000005751 Copper oxide Substances 0.000 description 14
- 229910000431 copper oxide Inorganic materials 0.000 description 14
- 210000000613 ear canal Anatomy 0.000 description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 14
- 239000013078 crystal Substances 0.000 description 13
- 230000007246 mechanism Effects 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 239000000853 adhesive Substances 0.000 description 11
- 230000001070 adhesive effect Effects 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 238000001035 drying Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000007943 implant Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 238000005304 joining Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 239000013543 active substance Substances 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- 239000000956 alloy Substances 0.000 description 7
- 229910045601 alloy Inorganic materials 0.000 description 7
- 239000002131 composite material Substances 0.000 description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
- 229910052737 gold Inorganic materials 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 229910052697 platinum Inorganic materials 0.000 description 7
- 229940009188 silver Drugs 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 206010017533 Fungal infection Diseases 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 238000002266 amputation Methods 0.000 description 5
- 230000006907 apoptotic process Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 210000004087 cornea Anatomy 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
- 208000035143 Bacterial infection Diseases 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- 206010062207 Mycobacterial infection Diseases 0.000 description 4
- 208000031888 Mycoses Diseases 0.000 description 4
- 229920001963 Synthetic biodegradable polymer Polymers 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 208000022362 bacterial infectious disease Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 230000024245 cell differentiation Effects 0.000 description 4
- 230000003915 cell function Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000001010 compromised effect Effects 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 210000001255 hallux Anatomy 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 229910052718 tin Inorganic materials 0.000 description 4
- 239000011135 tin Substances 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 239000011358 absorbing material Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000002195 soluble material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000021386 Sjogren Syndrome Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046851 Uveitis Diseases 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000003462 bioceramic Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000013590 bulk material Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 208000008025 hordeolum Diseases 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 201000004614 iritis Diseases 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000282 nail Anatomy 0.000 description 2
- 201000002575 ocular melanoma Diseases 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 2
- 229920000218 poly(hydroxyvalerate) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000005381 potential energy Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 201000004700 rosacea Diseases 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 210000003454 tympanic membrane Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 206010002515 Animal bite Diseases 0.000 description 1
- 241001527902 Aratus Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 206010008263 Cervical dysplasia Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000005373 Dyshidrotic Eczema Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 201000005708 Granuloma Annulare Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010022013 Ingrowing nail Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 206010024612 Lipoma Diseases 0.000 description 1
- 208000000185 Localized scleroderma Diseases 0.000 description 1
- 206010068773 Mechanical urticaria Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 229920002821 Modacrylic Polymers 0.000 description 1
- 206010027982 Morphoea Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 206010034277 Pemphigoid Diseases 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 208000006311 Pyoderma Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010042033 Stevens-Johnson syndrome Diseases 0.000 description 1
- 231100000168 Stevens-Johnson syndrome Toxicity 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 241000159241 Toxicodendron Species 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 206010064899 Vulvovaginal mycotic infection Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 201000010272 acanthosis nigricans Diseases 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229920005822 acrylic binder Polymers 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 210000003447 amputation stump Anatomy 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000002303 anti-venom Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000029586 bacterial cell surface binding Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940000031 blood and blood forming organ drug Drugs 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 description 1
- 208000000594 bullous pemphigoid Diseases 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 201000000652 cercarial dermatitis Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000037369 collagen remodeling Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 201000000409 dermatographia Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940099371 diacetylated monoglycerides Drugs 0.000 description 1
- 210000000188 diaphragm Anatomy 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000013046 dyshidrosis Diseases 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000007756 gravure coating Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- HIFJCPQKFCZDDL-ACWOEMLNSA-N iloprost Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]21 HIFJCPQKFCZDDL-ACWOEMLNSA-N 0.000 description 1
- 229960002240 iloprost Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- FPCCSQOGAWCVBH-UHFFFAOYSA-N ketanserin Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(CCN2C(C3=CC=CC=C3NC2=O)=O)CC1 FPCCSQOGAWCVBH-UHFFFAOYSA-N 0.000 description 1
- 229960005417 ketanserin Drugs 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 206010024428 lichen nitidus Diseases 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000002365 multiple layer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 206010035114 pityriasis rosea Diseases 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 201000011414 pompholyx Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 210000004879 pulmonary tissue Anatomy 0.000 description 1
- 239000002296 pyrolytic carbon Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000008791 toxic response Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000010388 wound contraction Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- Materials For Medical Uses (AREA)
- Primary Cells (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/784,088 | 2004-02-19 | ||
| US10/784,088 US7457667B2 (en) | 2004-02-19 | 2004-02-19 | Current producing surface for a wound dressing |
| PCT/US2005/005355 WO2005079913A1 (en) | 2004-02-19 | 2005-02-18 | Batteries and methods of manufacture and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005215805A1 AU2005215805A1 (en) | 2005-09-01 |
| AU2005215805B2 true AU2005215805B2 (en) | 2010-11-11 |
Family
ID=34861401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005215805A Ceased AU2005215805B2 (en) | 2004-02-19 | 2005-02-18 | Batteries and methods of manufacture and use |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US7457667B2 (https=) |
| EP (1) | EP1715915B1 (https=) |
| JP (2) | JP2007522887A (https=) |
| AU (1) | AU2005215805B2 (https=) |
| CA (1) | CA2553121C (https=) |
| IL (1) | IL177587A (https=) |
| TW (1) | TWI280142B (https=) |
| WO (1) | WO2005079913A1 (https=) |
Families Citing this family (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
| US6861570B1 (en) | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
| US8455710B2 (en) * | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
| US5814094A (en) | 1996-03-28 | 1998-09-29 | Becker; Robert O. | Iontopheretic system for stimulation of tissue healing and regeneration |
| US8801681B2 (en) | 1995-09-05 | 2014-08-12 | Argentum Medical, Llc | Medical device |
| US8734421B2 (en) * | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
| US7480530B2 (en) | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Device for treatment of barrier membranes |
| US20050182443A1 (en) | 2004-02-18 | 2005-08-18 | Closure Medical Corporation | Adhesive-containing wound closure device and method |
| US7662176B2 (en) * | 2004-02-19 | 2010-02-16 | Vomaris Innovations, Inc. | Footwear apparatus and methods of manufacture and use |
| US7904147B2 (en) * | 2004-02-19 | 2011-03-08 | Vomaris Innovations, Inc. | Substantially planar article and methods of manufacture |
| US20070088392A1 (en) * | 2004-02-19 | 2007-04-19 | Skiba Jeffry B | Bedding articles and methods of manufacture and use |
| US7457667B2 (en) * | 2004-02-19 | 2008-11-25 | Silverleaf Medical Products, Inc. | Current producing surface for a wound dressing |
| US20060009099A1 (en) | 2004-07-12 | 2006-01-12 | Closure Medical Corporation | Adhesive-containing wound closure device and method |
| US20090227930A1 (en) * | 2004-07-15 | 2009-09-10 | Crisp William E | Hygiene materials and absorbents |
| US20100069813A1 (en) * | 2004-07-15 | 2010-03-18 | Crisp William E | Wound dressings |
| US8417352B2 (en) * | 2004-10-19 | 2013-04-09 | Meagan Medical, Inc. | System and method for stimulating sensory nerves |
| CN101124010B (zh) * | 2004-10-19 | 2012-09-26 | 国际复原科技公司（贸易用名Rs医药公司） | 皮肤感觉感受器的电刺激方法和装置 |
| US20060235471A1 (en) * | 2005-04-14 | 2006-10-19 | Yu Eukki Q | Biological chip |
| US20080058915A1 (en) * | 2006-09-06 | 2008-03-06 | Chun-Min Chang | Membrane mask with acupuncture and massage functions and manufacturing methods |
| WO2008037262A1 (en) * | 2006-09-28 | 2008-04-03 | Stormøllen A/S | Wound healing composition comprising phosphate, iron and copper |
| US9539062B2 (en) | 2006-10-16 | 2017-01-10 | Natural Dental Implants, Ag | Methods of designing and manufacturing customized dental prosthesis for periodontal or osseointegration and related systems |
| US10426578B2 (en) | 2006-10-16 | 2019-10-01 | Natural Dental Implants, Ag | Customized dental prosthesis for periodontal or osseointegration and related systems |
| US8602780B2 (en) * | 2006-10-16 | 2013-12-10 | Natural Dental Implants, Ag | Customized dental prosthesis for periodontal or osseointegration and related systems and methods |
| US20080122582A1 (en) * | 2006-11-29 | 2008-05-29 | Texas Instruments Incorporated | Location Based Portable Device Feature Disabler |
| US8287475B2 (en) * | 2006-12-18 | 2012-10-16 | Technology Capital Investors, Llc | Apparatus and method for applying an electrostatic field to a wound or scar to promote healing thereof |
| CA2721377C (en) | 2008-04-23 | 2017-03-28 | Elc Management Llc | Microcurrent-generating topical or cosmetic systems, and methods of making and using the same |
| US8150525B2 (en) | 2008-08-27 | 2012-04-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment of hyperhydrosis |
| WO2012037445A2 (en) | 2010-09-17 | 2012-03-22 | Drexel University | Novel applications for alliform carbon |
| US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
| SG174922A1 (en) * | 2009-03-27 | 2011-11-28 | Ethicon Inc | Medical devices with galvanic particulates |
| CA2764680A1 (en) * | 2009-06-15 | 2010-12-23 | Elc Management Llc | Microcurrent-generating topical or cosmetic systems, and methods of making and using the same |
| US8025120B2 (en) * | 2009-06-26 | 2011-09-27 | Eddy Patrick E | Stethoscope and antimicrobial cover |
| EP2470257B1 (en) | 2009-08-27 | 2015-03-04 | Silver Bullet Therapeutics Inc. | Bone implants for the treatment of infection |
| US9821094B2 (en) | 2014-06-11 | 2017-11-21 | Silver Bullet Therapeutics, Inc. | Coatings for the controllable release of antimicrobial metal ions |
| US10265435B2 (en) | 2009-08-27 | 2019-04-23 | Silver Bullet Therapeutics, Inc. | Bone implant and systems and coatings for the controllable release of antimicrobial metal ions |
| US8927004B1 (en) | 2014-06-11 | 2015-01-06 | Silver Bullet Therapeutics, Inc. | Bioabsorbable substrates and systems that controllably release antimicrobial metal ions |
| US9114197B1 (en) | 2014-06-11 | 2015-08-25 | Silver Bullett Therapeutics, Inc. | Coatings for the controllable release of antimicrobial metal ions |
| EP2498867B1 (en) | 2009-11-13 | 2016-12-21 | Johnson & Johnson Consumer Inc. | Galvanic skin treatment device |
| US8666471B2 (en) * | 2010-03-17 | 2014-03-04 | The Board Of Trustees Of The University Of Illinois | Implantable biomedical devices on bioresorbable substrates |
| US9752932B2 (en) | 2010-03-10 | 2017-09-05 | Drexel University | Tunable electro-optic filter stack |
| WO2011127252A2 (en) | 2010-04-07 | 2011-10-13 | Proteus Biomedical, Inc. | Miniature ingestible device |
| EP2558107B1 (en) | 2010-04-13 | 2018-07-11 | KCI Licensing, Inc. | Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
| US8795257B2 (en) * | 2010-07-19 | 2014-08-05 | Kci Licensing, Inc. | Systems and methods for electrically detecting the presence of exudate in dressings |
| EP3037066B1 (en) | 2010-11-12 | 2017-08-16 | Silver Bullet Therapeutics Inc. | Bone implant that controllably releases silver |
| JP2012234057A (ja) * | 2011-05-02 | 2012-11-29 | Elpida Memory Inc | フォトマスクおよび半導体装置 |
| EP2736594B1 (en) * | 2011-07-25 | 2016-09-14 | NeuroNexus Technologies, Inc. | Neuromodulation transfection system with passive fluid delivery |
| JP2015503425A (ja) * | 2012-01-16 | 2015-02-02 | テキソ メディカル アーペーエス | 創傷の治療のためのデバイス |
| HK1210076A1 (en) * | 2012-06-29 | 2016-04-15 | Johnson & Johnson Vision Care, Inc. | Method and ophthalmic device for galvanic healing of an eye |
| US9295854B2 (en) | 2012-11-28 | 2016-03-29 | Point Source, Inc. | Light and bioelectric therapy pad |
| US9962546B2 (en) | 2013-02-21 | 2018-05-08 | Meagan Medical, Inc. | Cutaneous field stimulation with disposable and rechargeable components |
| US9406969B2 (en) * | 2013-03-15 | 2016-08-02 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form three-dimensional biocompatible energization elements |
| JP6377385B2 (ja) * | 2013-03-28 | 2018-08-22 | 株式会社 東北テクノアーチ | 生体組織貼付用キット及び生体組織貼付用パッチ |
| US9511215B2 (en) * | 2013-05-02 | 2016-12-06 | Vomaris Innovations, Inc. | Expandable wound dressings |
| US10058455B2 (en) | 2013-06-10 | 2018-08-28 | Ultramend, Inc. | Nano-enhanced wound dressing |
| US10687536B2 (en) | 2013-06-27 | 2020-06-23 | Microlin, Llc | Disposable wipes for energized treatment agent |
| US10808211B2 (en) | 2013-06-27 | 2020-10-20 | Microlin, Llc | Disposable wipes with treatment agent safely formed insitu |
| EP3013203A4 (en) | 2013-06-27 | 2017-03-22 | Microlin, LLC | Anti-microbial disinfectant wipe and method of use |
| US10260030B2 (en) | 2013-06-27 | 2019-04-16 | Microlin, Llc | Disposable wipes with peracetic acid treatment agent |
| US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
| US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
| US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
| EP3151797B1 (en) * | 2014-06-03 | 2021-02-17 | Vomaris Innovations, Inc. | Methods and devices for treating the skin |
| US9452242B2 (en) | 2014-06-11 | 2016-09-27 | Silver Bullet Therapeutics, Inc. | Enhancement of antimicrobial silver, silver coatings, or silver platings |
| US9452293B2 (en) | 2014-06-19 | 2016-09-27 | Inspire Medical Systems, Inc. | Hybrid communication channel for communicating with an implantable medical device |
| USD824525S1 (en) * | 2014-09-25 | 2018-07-31 | Ethicon Llc | Release paper for wound treament devices |
| JP6385775B2 (ja) * | 2014-09-26 | 2018-09-05 | 株式会社 東北テクノアーチ | 創傷治癒用パッチ |
| US20160089309A1 (en) * | 2014-09-29 | 2016-03-31 | Elc Management Llc | Targeted and individualized delivery of skincare treatments with microcurrent in a mask or patch form |
| US20160089534A1 (en) * | 2014-09-29 | 2016-03-31 | Elc Management Llc | Targeted And Individualized Delivery Of Skincare Treatments With Micro-Current In A Mask Or Patch Form |
| USD825062S1 (en) * | 2014-11-11 | 2018-08-07 | Medline Industries, Inc. | Bandage |
| US10555521B2 (en) | 2014-12-30 | 2020-02-11 | Micrulia LLC | Disposable wipes for optional disinfection, deodorization, and/or sterilization and methods of use thereof |
| TWI581771B (zh) * | 2015-04-14 | 2017-05-11 | 財團法人紡織產業綜合研究所 | 傷口護理用敷材 |
| US20180154130A1 (en) * | 2015-06-02 | 2018-06-07 | Vomaris Innovations, Inc. | Methods and devices for treating the cornea |
| US11090482B2 (en) * | 2015-06-03 | 2021-08-17 | Vomaris Innovations, Inc. | Method and devices for treating muscles |
| US11571490B2 (en) | 2015-06-29 | 2023-02-07 | 3M Innovative Properties Company | Anti-microbial articles and methods of using same |
| WO2017035280A1 (en) * | 2015-08-24 | 2017-03-02 | Nugene, Inc. | Skin damage healing aids and dressings |
| US20180243550A1 (en) * | 2015-08-26 | 2018-08-30 | Vomaris Innovations, Inc. | Methods and devices for tissue treatment |
| CN107925094B (zh) | 2015-08-28 | 2021-03-05 | 芬兰国家技术研究中心股份公司 | 用于电化电池的装置 |
| JP6703125B2 (ja) | 2015-10-30 | 2020-06-03 | ロレン・カウンティー・コミュニティー・カレッジ・イノヴェイション・ファウンデイション | 創傷治療装置及び方法 |
| WO2017099973A1 (en) * | 2015-12-07 | 2017-06-15 | Vomaris Innovations, Inc. | Iontophoresis devices and methods of use |
| EP3184124B1 (de) * | 2015-12-21 | 2019-06-26 | Paul Hartmann AG | Wundsystem enthaltend zwei stoffe |
| US9387125B1 (en) | 2016-01-26 | 2016-07-12 | Vive Wear Llc | Sock for treatment of foot and leg wounds, methods of use and manufacture |
| WO2017151715A1 (en) * | 2016-03-01 | 2017-09-08 | Vomaris Innovations, Inc. | Bioelectric devices for use on specific areas of the body |
| US10792024B2 (en) | 2016-09-28 | 2020-10-06 | Ethicon, Inc. | Scaffolds with channels for joining layers of tissue at discrete points |
| US10687986B2 (en) | 2016-09-29 | 2020-06-23 | Ethicon, Inc. | Methods and devices for skin closure |
| US10420929B2 (en) * | 2016-09-29 | 2019-09-24 | Aganyan Inc. | Systems and methods for electrostimulation therapy |
| USD848624S1 (en) | 2016-09-29 | 2019-05-14 | Ethicon, Inc. | Release paper for wound treatment devices |
| US10470934B2 (en) | 2016-09-29 | 2019-11-12 | Ethicon, Inc. | Methods and devices for skin closure |
| US20190275191A1 (en) * | 2016-10-19 | 2019-09-12 | 3M Innovative Properties Company | Anti-microbial articles |
| EP3528889A4 (en) | 2016-10-21 | 2020-06-03 | Ohio State Innovation Foundation | ANTIMICROBIAL Wound Care Association |
| WO2018132298A1 (en) * | 2017-01-11 | 2018-07-19 | Vomaris Innovations, Inc. | Dressing application systems and devices |
| FR3063228A1 (fr) * | 2017-02-27 | 2018-08-31 | L'oreal | Pile electrochimique pour diminuer la transpiration |
| CA3055201A1 (en) | 2017-03-03 | 2018-09-07 | Ohio State Innovation Foundation | Energy generation from fabric electrochemistry |
| EP3595515A4 (en) | 2017-03-14 | 2020-12-30 | University of Connecticut | BIODEGRADABLE PRESSURE SENSOR |
| US20180271505A1 (en) | 2017-03-23 | 2018-09-27 | Ethicon, Inc. | Scaffolds for Joining Layers of Tissue at Discrete Points |
| US10470935B2 (en) | 2017-03-23 | 2019-11-12 | Ethicon, Inc. | Skin closure systems and devices of improved flexibility and stretchability for bendable joints |
| US11504446B2 (en) | 2017-04-25 | 2022-11-22 | Ethicon, Inc. | Skin closure devices with self-forming exudate drainage channels |
| US10967082B2 (en) | 2017-11-08 | 2021-04-06 | Parasol Medical, Llc | Method of limiting the spread of norovirus within a cruise ship |
| CA3082015A1 (en) * | 2017-11-08 | 2019-05-16 | Molnlycke Health Care Ab | Novel biosensor and related wound dressing system |
| KR102044605B1 (ko) | 2017-11-20 | 2019-11-14 | 한국생산기술연구원 | 밴드형 패브릭 센서 및 그 제조방법 |
| US11124901B2 (en) | 2017-11-27 | 2021-09-21 | First Step Holdings, Llc | Composite fabric, method for forming composite fabric, and use of a composite matter fabric |
| US10864058B2 (en) | 2018-03-28 | 2020-12-15 | Parasol Medical, Llc | Antimicrobial treatment for a surgical headlamp system |
| US10993708B2 (en) | 2018-07-31 | 2021-05-04 | Ethicon, Inc. | Skin closure devices with interrupted closure |
| US11311715B2 (en) | 2018-10-12 | 2022-04-26 | Cymmetrik Enterprise Co., Ltd. | Self-powered sheet |
| US11826495B2 (en) | 2019-03-01 | 2023-11-28 | University Of Connecticut | Biodegradable piezoelectric ultrasonic transducer system |
| AU2020311816B2 (en) | 2019-07-11 | 2023-08-10 | Vomaris Innovations, Inc. | Methods and devices for treating external fixation sites |
| CN110625270A (zh) * | 2019-11-05 | 2019-12-31 | 大族激光科技产业集团股份有限公司 | 一种超快激光的加工方法 |
| CN115023244A (zh) * | 2019-12-09 | 2022-09-06 | 3M创新有限公司 | 抗微生物制品 |
| US12151036B2 (en) | 2020-01-10 | 2024-11-26 | Grant Kitchen | Electrification system for preventing transmission of pathogens by dermal contact |
| KR102551684B1 (ko) * | 2020-02-07 | 2023-07-06 | 바이오센서연구소 주식회사 | 산화-환원 반응을 이용한 환부 치료 장치 |
| WO2021158083A1 (ko) * | 2020-02-07 | 2021-08-12 | 바이오센서연구소 주식회사 | 산화-환원 반응을 이용한 환부 치료 장치 |
| US11745001B2 (en) | 2020-03-10 | 2023-09-05 | University Of Connecticut | Therapeutic bandage |
| US12544526B2 (en) | 2020-03-27 | 2026-02-10 | Arthrex, Inc. | Anti-microbial heat and moisture exchangers |
| US12491290B2 (en) | 2020-06-08 | 2025-12-09 | University Of Connecticut | Biodegradable piezoelectric composite materials |
| US11849782B2 (en) | 2020-09-11 | 2023-12-26 | American Biomedical Group Inc. | Facemask |
| US11673007B2 (en) | 2020-12-24 | 2023-06-13 | Saied Tousi | Personal protective equipment that employs nanoparticles of two different metals that generate an electric field for inactivating microorganisms |
| KR102386028B1 (ko) * | 2021-01-06 | 2022-04-14 | 주식회사 셀바이오휴먼텍 | 전위차 소재를 이용한 전도성 패턴이 구비된 창상피복재 시트 및 그 제조방법 |
| JP2021073067A (ja) * | 2021-02-18 | 2021-05-13 | 一般財団法人日本美容鍼灸マッサージ協会 | 健康器具 |
| EP4436527A1 (en) * | 2021-11-26 | 2024-10-02 | Ossur Iceland Ehf | Prosthetic device having a sacrificial anode |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4585652A (en) * | 1984-11-19 | 1986-04-29 | Regents Of The University Of Minnesota | Electrochemical controlled release drug delivery system |
| WO2001012157A1 (en) * | 1999-08-18 | 2001-02-22 | Microchips, Inc. | Thermally-activated microchip chemical delivery devices |
| US20020188282A1 (en) * | 2001-02-13 | 2002-12-12 | Robert Greenberg | Implantable drug delivery device |
Family Cites Families (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US116562A (en) | 1871-07-04 | Improvement in medicated voltaic plasters | ||
| US384608A (en) * | 1888-06-19 | Chair | ||
| US175974A (en) | 1876-04-11 | Improvement in electro-medical plasters | ||
| US167162A (en) | 1875-08-31 | Improvement in electro-therapeutic | ||
| US393741A (en) | 1888-12-04 | Voltaic plaster | ||
| US222276A (en) | 1879-12-02 | Improvement in combined galvanic and medicated pad | ||
| US3774592A (en) * | 1971-12-16 | 1973-11-27 | Xerox Corp | Method for providing an improved body electrode electrical connection |
| US3848608A (en) * | 1973-07-23 | 1974-11-19 | Gen Electric | Subject integument spatial stimulator |
| US4034750A (en) * | 1975-04-22 | 1977-07-12 | Maurice Seiderman | Electrochemically linking collagen fibrils to animal tissue |
| US4767401A (en) * | 1975-04-22 | 1988-08-30 | Maurice Seiderman | Iontophoretic administration of ionizable or polar medicaments to a mammalian body |
| US4067342A (en) * | 1976-04-06 | 1978-01-10 | Medtronic, Inc. | Tape electrode |
| US4211222A (en) * | 1976-08-25 | 1980-07-08 | Robert Tapper | Iontophoretic burn-protection method |
| US4142521A (en) * | 1976-12-23 | 1979-03-06 | Hoffmann-La Roche Inc. | Electrostatic soft tissue wound repair enhancement |
| GB1588933A (en) | 1977-07-08 | 1981-04-29 | Seiderman M | Dressings for use on a mammalian body and capable of forming a galvanic couple therewith |
| US4528265A (en) * | 1982-05-11 | 1985-07-09 | Becker Robert O | Processes and products involving cell modification |
| US4529623A (en) * | 1982-09-13 | 1985-07-16 | Charcoal Cloth Ltd. | Activated carbon products and their manufacture |
| WO1984004045A1 (fr) * | 1983-04-15 | 1984-10-25 | Jack Kenneth Ibbott | Procede therapeutique et appareil utilisant une batterie plate |
| US4540604A (en) * | 1983-08-25 | 1985-09-10 | E. I. Du Pont De Nemours And Company | Thick film conductor compositions |
| NZ206154A (en) * | 1983-11-04 | 1988-01-08 | Claudio Petronelli | Garlic crusher with rotatable plunger |
| US4569673A (en) * | 1984-01-12 | 1986-02-11 | Battelle Development Corporation | Bacterial barrier for indwelling catheters and other medical devices |
| US4937323A (en) * | 1984-03-27 | 1990-06-26 | University Of Medicine And Dentistry Of New Jersey | Method and apparatus for lidc enhanced wound healing using biocompatible tissue ingrowth implants |
| JPS6130917A (ja) * | 1984-07-19 | 1986-02-13 | 富士電気化学株式会社 | ３相４線式用ノイズフイルタ |
| GB8509978D0 (en) * | 1985-04-18 | 1985-05-30 | Juhasz L | Wound dressings |
| US4852571A (en) * | 1987-09-03 | 1989-08-01 | Marquette Electronics | Disposable biopotential electrode |
| IL86076A (en) * | 1988-04-14 | 1992-12-01 | Inventor S Funding Corp Ltd | Transdermal drug delivery device |
| IL91193A (en) * | 1989-08-02 | 1996-01-19 | Yeda Res & Dev | Tumor detection system |
| JP2843603B2 (ja) | 1989-08-23 | 1999-01-06 | 株式会社ユアサコーポレーション | イオントフォレーシス装置 |
| DE4014913C2 (de) * | 1990-05-10 | 1996-05-15 | Lohmann Therapie Syst Lts | Miniaturisiertes transdermales therapeutisches System für die Iontophorese |
| US5158537A (en) * | 1990-10-29 | 1992-10-27 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
| CA2033107C (en) * | 1990-12-24 | 2001-06-12 | Robert Edward Burrell | Actively sterile surfaces |
| US5405317A (en) * | 1991-05-03 | 1995-04-11 | Alza Corporation | Iontophoretic delivery device |
| WO1993000857A1 (en) * | 1991-07-12 | 1993-01-21 | Ludlow Corporation | Biomedical electrode |
| US5360440A (en) * | 1992-03-09 | 1994-11-01 | Boston Scientific Corporation | In situ apparatus for generating an electrical current in a biological environment |
| WO1993019679A1 (en) * | 1992-04-07 | 1993-10-14 | The Johns Hopkins University | A percutaneous mechanical fragmentation catheter system |
| GEP20002074B (en) * | 1992-05-19 | 2000-05-10 | Westaim Tech Inc Ca | Modified Material and Method for its Production |
| US5681575A (en) * | 1992-05-19 | 1997-10-28 | Westaim Technologies Inc. | Anti-microbial coating for medical devices |
| US6287484B1 (en) * | 1992-11-12 | 2001-09-11 | Robert Hausslein | Iontophoretic material |
| US5322520A (en) * | 1992-11-12 | 1994-06-21 | Implemed, Inc. | Iontophoretic structure for medical devices |
| US5298017A (en) * | 1992-12-29 | 1994-03-29 | Alza Corporation | Layered electrotransport drug delivery system |
| JPH07108065A (ja) * | 1993-10-13 | 1995-04-25 | Konseputsu:Kk | 皮膚に貼用される健康増進具 |
| US5454886A (en) * | 1993-11-18 | 1995-10-03 | Westaim Technologies Inc. | Process of activating anti-microbial materials |
| US5469673A (en) * | 1994-04-06 | 1995-11-28 | Raynor; Dennis L. | Integrated residential dwelling units |
| US5578022A (en) * | 1995-04-12 | 1996-11-26 | Scherson; Daniel A. | Oxygen producing bandage and method |
| US6861570B1 (en) * | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
| US5814094A (en) * | 1996-03-28 | 1998-09-29 | Becker; Robert O. | Iontopheretic system for stimulation of tissue healing and regeneration |
| US6087549A (en) * | 1997-09-22 | 2000-07-11 | Argentum International | Multilayer laminate wound dressing |
| US8455710B2 (en) * | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
| JPH09215755A (ja) * | 1996-02-09 | 1997-08-19 | Poritoronikusu:Kk | 皮接治療具 |
| US5944685A (en) * | 1996-02-09 | 1999-08-31 | Polytronics, Ltd. | Skin-contact type medical treatment apparatus |
| JPH09215756A (ja) * | 1996-02-14 | 1997-08-19 | Masayuki Matsuda | イオン湿布およびその製造方法 |
| JP3080874B2 (ja) | 1996-02-14 | 2000-08-28 | 松下電子工業株式会社 | クリーンルームの床組構造 |
| US5741224A (en) * | 1996-04-16 | 1998-04-21 | Implemed, Inc. | Iontophoretic material |
| US5759564A (en) * | 1996-04-16 | 1998-06-02 | Implemed, Inc. | Iontophoretic material |
| US5772688A (en) * | 1996-06-20 | 1998-06-30 | Polytronics, Ltd. | Skin-contact type medical treatment apparatus |
| US6333093B1 (en) * | 1997-03-17 | 2001-12-25 | Westaim Biomedical Corp. | Anti-microbial coatings having indicator properties and wound dressings |
| US5782788A (en) * | 1997-03-21 | 1998-07-21 | Widemire; Dewitt P. | Wound dressing |
| US5904712A (en) * | 1997-06-12 | 1999-05-18 | Axelgaard Manufacturing Co., Ltd. | Current-controlling electrode |
| US6365220B1 (en) * | 1997-11-03 | 2002-04-02 | Nucryst Pharmaceuticals Corp. | Process for production of actively sterile surfaces |
| US5974344A (en) * | 1998-03-02 | 1999-10-26 | Shoemaker, Ii; Charles | Wound care electrode |
| US6757560B1 (en) * | 1999-04-09 | 2004-06-29 | Novosis Pharma Ag | Transdermal delivery system (TDS) with electrode network |
| JP3507437B2 (ja) * | 1998-05-13 | 2004-03-15 | シグナス， インコーポレイテッド | 経皮サンプリング系のための収集アセンブリ |
| AU766913B2 (en) * | 1998-11-02 | 2003-10-23 | Alza Corporation | Electrotransport device including a compatible antimicrobial agent |
| JP2000174400A (ja) * | 1998-12-10 | 2000-06-23 | Alps Electric Co Ltd | フレキシブルプリント基板 |
| US6522918B1 (en) * | 2000-02-09 | 2003-02-18 | William E. Crisp | Electrolytic device |
| US6306419B1 (en) * | 2000-02-23 | 2001-10-23 | Aegis Biosciences, Llc | Medical uses of styrene sulfonate polymers |
| JP2003530156A (ja) * | 2000-04-06 | 2003-10-14 | ユニバーシティ ライセンス ホールディングス インコーポレイテッド | 創傷治癒を促進するための組成物および方法 |
| US6989156B2 (en) * | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
| US6738662B1 (en) * | 2000-11-21 | 2004-05-18 | Steven R. Frank | Electrolytic substance infusion device |
| US8286845B2 (en) * | 2000-11-27 | 2012-10-16 | Boston Scientific Scimed, Inc. | Full thickness resection device control handle |
| US20020161405A1 (en) * | 2001-04-30 | 2002-10-31 | Drake Gene F. | Electrical youth current cure |
| ITMI20010260U1 (it) * | 2001-05-09 | 2002-11-11 | Gafitex S R L | Articolo sanitario, da portare a contatto della pelle, atto ad esplicare effetti di metalloterapia |
| US6653014B2 (en) * | 2001-05-30 | 2003-11-25 | Birch Point Medical, Inc. | Power sources for iontophoretic drug delivery systems |
| US6631294B2 (en) * | 2001-06-01 | 2003-10-07 | Biofisica, Llc | Apparatus and methods for facilitating wound healing |
| US6898465B2 (en) * | 2001-10-17 | 2005-05-24 | The Ludlow Company Ip | Differential gel body for a medical stimulation electrode |
| US7643874B2 (en) * | 2001-10-24 | 2010-01-05 | Power Paper Ltd. | Dermal patch |
| US20050125012A1 (en) * | 2002-06-28 | 2005-06-09 | Houser Russell A. | Hemostatic patch for treating congestive heart failure |
| WO2004022033A1 (en) | 2002-09-04 | 2004-03-18 | Microchips, Inc. | Method and device for the controlled delivery of parathyroid hormone |
| WO2004028379A1 (en) * | 2002-09-25 | 2004-04-08 | Flock, Stephen, T. | Microsurgical tissue treatment system |
| US6848608B2 (en) * | 2002-10-01 | 2005-02-01 | Cabot Corporation | Method of bonding sputtering target materials |
| US7043308B2 (en) * | 2003-02-19 | 2006-05-09 | Stimu-Heal, Inc. | Surface electrode for electrical stimulation of tissue |
| ATE424884T1 (de) * | 2003-03-31 | 2009-03-15 | Alza Corp | Elektrotransportvorrichtung mit einem behältergehäuse mit einem biegsamen leitfähigen element |
| US20040199086A1 (en) * | 2003-04-03 | 2004-10-07 | Crisp William E. | Urinary tract catheter |
| US7476222B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of reducing the appearance of pigmentation with galvanic generated electricity |
| US20040265395A1 (en) * | 2003-06-30 | 2004-12-30 | Ying Sun | Device for delivery of reducing agents to barrier membranes |
| US7477938B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Cosumer Companies, Inc. | Device for delivery of active agents to barrier membranes |
| US7477941B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of exfoliating the skin with electricity |
| US7480530B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Device for treatment of barrier membranes |
| US7486989B2 (en) * | 2003-06-30 | 2009-02-03 | Johnson & Johnson Consumer Companies, Inc. | Device for delivery of oxidizing agents to barrier membranes |
| US8734421B2 (en) * | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
| US7479133B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating acne and rosacea with galvanic generated electricity |
| US7477939B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating a wound with galvanic generated electricity |
| US7477940B2 (en) * | 2003-06-30 | 2009-01-13 | J&J Consumer Companies, Inc. | Methods of administering an active agent to a human barrier membrane with galvanic generated electricity |
| US7160313B2 (en) * | 2003-07-28 | 2007-01-09 | Helena Laboratories | Load-controlled device for a patterned skin incision |
| WO2005023361A2 (en) * | 2003-09-10 | 2005-03-17 | Power Paper Ltd. | Disposable electric bandage |
| US7780692B2 (en) * | 2003-12-05 | 2010-08-24 | Onset Medical Corporation | Expandable percutaneous sheath |
| US20050125006A1 (en) * | 2003-12-09 | 2005-06-09 | Nady Nady E. | Device for sealing a cervical canal |
| US7457667B2 (en) | 2004-02-19 | 2008-11-25 | Silverleaf Medical Products, Inc. | Current producing surface for a wound dressing |
| US20060015052A1 (en) * | 2004-07-15 | 2006-01-19 | Crisp William E | Wound dressing |
| US7495146B2 (en) * | 2004-07-15 | 2009-02-24 | Vivo Ltd. Partnership | Wound dressing |
| US20060141015A1 (en) | 2004-12-07 | 2006-06-29 | Centre Des Technologies Textiles | Antimicrobial material |
-
2004
- 2004-02-19 US US10/784,088 patent/US7457667B2/en not_active Expired - Lifetime
-
2005
- 2005-02-17 TW TW094104619A patent/TWI280142B/zh not_active IP Right Cessation
- 2005-02-18 AU AU2005215805A patent/AU2005215805B2/en not_active Ceased
- 2005-02-18 CA CA2553121A patent/CA2553121C/en not_active Expired - Lifetime
- 2005-02-18 JP JP2006554259A patent/JP2007522887A/ja not_active Withdrawn
- 2005-02-18 WO PCT/US2005/005355 patent/WO2005079913A1/en not_active Ceased
- 2005-02-18 EP EP05723362A patent/EP1715915B1/en not_active Expired - Lifetime
- 2005-02-18 US US11/061,235 patent/US7672719B2/en active Active
-
2006
- 2006-08-20 IL IL177587A patent/IL177587A/en not_active IP Right Cessation
-
2008
- 2008-10-13 US US12/250,183 patent/US7813806B2/en not_active Expired - Lifetime
-
2010
- 2010-02-01 US US12/697,993 patent/US8224439B2/en not_active Expired - Fee Related
-
2012
- 2012-02-15 JP JP2012030805A patent/JP5296234B2/ja not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4585652A (en) * | 1984-11-19 | 1986-04-29 | Regents Of The University Of Minnesota | Electrochemical controlled release drug delivery system |
| WO2001012157A1 (en) * | 1999-08-18 | 2001-02-22 | Microchips, Inc. | Thermally-activated microchip chemical delivery devices |
| US20020188282A1 (en) * | 2001-02-13 | 2002-12-12 | Robert Greenberg | Implantable drug delivery device |
Non-Patent Citations (1)
| Title |
|---|
| PATENT ABSTRACTS OF JAPAN vol. 015, no. 248 (C-0843), 25 June 1991 JP 03 080874 A * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2553121A1 (en) | 2005-09-01 |
| US20100312293A1 (en) | 2010-12-09 |
| US7813806B2 (en) | 2010-10-12 |
| IL177587A0 (en) | 2006-12-31 |
| US7457667B2 (en) | 2008-11-25 |
| JP2012161613A (ja) | 2012-08-30 |
| EP1715915B1 (en) | 2012-11-14 |
| WO2005079913A1 (en) | 2005-09-01 |
| US7672719B2 (en) | 2010-03-02 |
| US20090062723A1 (en) | 2009-03-05 |
| US8224439B2 (en) | 2012-07-17 |
| AU2005215805A1 (en) | 2005-09-01 |
| JP5296234B2 (ja) | 2013-09-25 |
| US20050192636A1 (en) | 2005-09-01 |
| TW200529892A (en) | 2005-09-16 |
| TWI280142B (en) | 2007-05-01 |
| EP1715915A1 (en) | 2006-11-02 |
| US20050187580A1 (en) | 2005-08-25 |
| JP2007522887A (ja) | 2007-08-16 |
| IL177587A (en) | 2010-12-30 |
| CA2553121C (en) | 2014-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005215805B2 (en) | Batteries and methods of manufacture and use | |
| US20230017025A1 (en) | Methods and devices for surgical pre-treatment | |
| US7495146B2 (en) | Wound dressing | |
| AU2016262720B2 (en) | Expandable wound dressings | |
| US7662176B2 (en) | Footwear apparatus and methods of manufacture and use | |
| US7904147B2 (en) | Substantially planar article and methods of manufacture | |
| ES2430688T3 (es) | Dispositivo médico | |
| US20060015052A1 (en) | Wound dressing | |
| JP2002516120A (ja) | 創傷治癒および鎮痛特性を有する多層導電性用具 | |
| JP4467311B2 (ja) | 導電性外傷用医薬材料及びその使用方法 | |
| JP2002536132A (ja) | 電気分解装置 | |
| TW202320884A (zh) | 產生腫瘤治療場的傳導墊片及其生產和使用方法 | |
| WO2026083126A2 (en) | Electro-stimulative, hydrophilic-hydrophobic dual-structured metallic mesh wound dressing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |